AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging
Loading...
Official URL
Full text at PDC
Publication date
2016
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
IOS Press
Citation
Ordoñez-Gutierrez, L., Fernandez-Perez, I., Herrera, J. L., Anton, M., Benito-Cuesta, I., & Wandosell, F. (2016). Aβpp/ps1 transgenic mice show sex differences in the cerebellum associated with aging. Journal of Alzheimer’s Disease, 54(2), 645-656. https://doi.org/10.3233/JAD-160572
Abstract
Cerebellar pathology has been related to presenilin 1 mutations in certain pedigrees of familial Alzheimer's disease. However, cerebellum tissue has not been intensively analyzed in transgenic models of mutant presenilins. Furthermore, the effect of the sex of the mice was not systematically analyzed, despite the fact that important gender differences in the evolution of the disease in the human population have been described. We analyzed whether the progression of amyloidosis in a double transgenic mouse, AβPP/PS1, is susceptible to aging and differentially affects males and females. The accumulation of amyloid in the cerebellum differentially affects males and females of the AβPP/PS1 transgenic line, which was found to be ten-fold higher in 15-month-old females. Amyloid-β accumulation was more evident in the molecular layer of the cerebellum, but glia reaction was only observed in the granular layer of the older mice. The sex divergence was also observed in other neuronal, survival, and autophagic markers. The cerebellum plays an important role in the evolution of the pathology in this transgenic mouse model. Sex differences could be crucial for a complete understanding of this disease. We propose that the human population could be studied in this way. Sex-specific treatment strategies in human populations could show a differential response to the therapeutic approach.












